Effect of Quetiapine on Marijuana Withdrawal and Relapse

Completed · Phase 2 · Has a placebo group

Conditions studied: Marijuana Smoking

In brief

The objective of this study is to investigate the interaction between marijuana and quetiapine, with the goal of using this information to improve marijuana treatment outcome.

Key facts

Study ID

NCT00743366

Run by

New York State Psychiatric Institute

People needed

20

Starts

2008-08-01

Expected to finish

2009-03-01

Last updated by the study team

2017-08-18

Who can join

Age: 21 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Current marijuana use:average of 2 marijuana cigarettes per day at least 4 times per week for the past 4 weeks
• Able to perform study procedures
• 21-45 years of age
• Women practicing an effective form of birth control (condoms, diaphragm, birth control, pill, IUD)
• Normal body weight

You may not qualify if…

• Current, repeated illicit drug use (other than marijuana)
• Presence of significant medical illness (e.g., diabetes, cardiovascular disease, hypertension, clinically significant abnormalities)
• History of heart disease or current conduction system disease as indicated by QRS duration > 0.11
• Request for drug treatment
• Current parole or probation
• Pregnancy or current lactation
• Recent history of significant violent behavior
• Major current Axis I psychopathology (major depressive disorder, bipolar disorder, suicide risk, schizophrenia)
• Current use of any prescription or over-the-counter medication
• Prior allergic or otherwise serious adverse reaction to quetiapine

Where it is running

• New York State Psychiatric Institute — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.